Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis
- PMID: 1033536
Toleracne to equine IgG after immunosuppression in patients with multiple sclerosis
Abstract
Fourteen patients with multiple sclerosis were given two tolerizing doses of equinine gammaglobulin followed by equine antilymphocyte globulin. Twelve were sufficiently tolerant to have no clinical symptoms of hypersensitivity, no skin reactivity and normal plasma clearance rates. Some tolerance was lost in the following months revealed by immediate wheal and flare skin reactions. No correlation between success in tolerance induction and beneficial effects on the disease process could be established in the short term follow-up period of this pilot study.
Similar articles
-
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.Clin Exp Immunol. 1975 Jul;21(1):13-22. Clin Exp Immunol. 1975. PMID: 810281 Free PMC article.
-
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.Clin Exp Immunol. 1975 Jul;21(1):1-12. Clin Exp Immunol. 1975. PMID: 1237376 Free PMC article.
-
Antilymphocyte globulin and adrenal steroids in the treatment of multiple sclerosis: short report based on seven cases.Boll Ist Sieroter Milan. 1979 Sep 30;58(4):339-43. Boll Ist Sieroter Milan. 1979. PMID: 553516
-
[Antilymphocytic globulin and its immunosuppressive action in experimental allergic encephalomyelitis and multiple sclerosis].Neurol Neurochir Pol. 1972 Jul-Aug;6(4):619-23. Neurol Neurochir Pol. 1972. PMID: 4564004 Review. Polish. No abstract available.
-
The evidence justifying immunosuppression therapy in multiple sclerosis.Proc R Soc Med. 1977 Dec;70(12):871-4. doi: 10.1177/003591577707001214. Proc R Soc Med. 1977. PMID: 202967 Free PMC article. Review. No abstract available.